![Dominic Borie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominic Borie
Hoofd Techniek/Wetenschap/O&O bij
CUE BIOPHARMA, INC.
Vermogen: 994 140 $ op 30-06-2026
Profiel
Dominic Borie is Chief Medical Officer, Head-Research & Development at Cue Biopharma, Inc. since 2026.
Former roles include President-Research & Development at Kyverna Therapeutics, Inc. from 2022 to 2025, VP, Head-External Research & Development at Horizon Therapeutics Ltd. (Ireland), Director-Transplantation Immunology Laboratory at Stanford University, Senior Medical Director at Genentech, Inc., Medical Director at Amgen, Inc., and Executive Director at Allogene Therapeutics, Inc. Education includes a doctorate from The University of Texas at Austin and an undergraduate degree from North Carolina State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 0,75% | 13-07-2026 | 31.500 ( 0,75% ) | 994 140 $ | 30-06-2026 |
Actieve functies van Dominic Borie
| Bedrijven | Functie | Begin |
|---|---|---|
| CUE BIOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | 13-07-2026 |
Eerdere bekende functies van Dominic Borie
| Bedrijven | Functie | Einde |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Algemeen Directeur | 13-10-2022 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AMGEN INC. | Hoofd Techniek/Wetenschap/O&O | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Opleiding van Dominic Borie
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
38
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Texas at Austin
 The University of Texas at Austin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Allogene Therapeutics, Inc.
 Allogene Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage immuno-oncology | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
